Related references
Note: Only part of the references are listed.Deciphering the MHC-associated peptidome: a review of naturally processed ligand data
Kerrie Vaughan et al.
EXPERT REVIEW OF PROTEOMICS (2017)
A Case for a Human Immuno-Peptidome Project Consortium
Etienne Caron et al.
IMMUNITY (2017)
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
Jennifer G. Abelin et al.
IMMUNITY (2017)
Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices
Moreno Di Marco et al.
JOURNAL OF IMMUNOLOGY (2017)
NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
Vanessa Jurtz et al.
JOURNAL OF IMMUNOLOGY (2017)
MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies
J. Patrick Murphy et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens
Michael S. Khodadoust et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Building proteomic tool boxes to monitor MHC class I and class II peptides
Frances-Rose Schumacher et al.
PROTEOMICS (2017)
Multi-level Strategy for Identifying Proteasome-Catalyzed Spliced Epitopes Targeted by CD8+ T Cells during Bacterial Infection
Anouk C. M. Platteel et al.
CELL REPORTS (2017)
The neoepitope landscape in pediatric cancers
Ti-Cheng Chang et al.
GENOME MEDICINE (2017)
Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity
Michal Bassani-Sternberg et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia
Stacy A. Malaker et al.
CANCER IMMUNOLOGY RESEARCH (2017)
The immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design
Ward Fleri et al.
FRONTIERS IN IMMUNOLOGY (2017)
Distorted Immunodominance by Linker Sequences or other Epitopes from a Second Protein Antigen During Antigen-Processing
AeRyon Kim et al.
SCIENTIFIC REPORTS (2017)
MHC-I Genotype Restricts the Oncogenic Mutational Landscape
Rachel Marty et al.
CELL (2017)
Identifying Abundant Immunotherapy and Other Targets in Solid Tumors Integrating RNA-seq and Mass Spectrometry Proteomics Data Sets
Wei Zhao et al.
CANCER JOURNAL (2017)
Mass spectrometry-based antigen discovery for cancer immunotherapy
Michal Bassani-Sternberg et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient
Markus W. Loeffler et al.
JOURNAL OF HEPATOLOGY (2016)
Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide-HLA Interactions
Michal Bassani-Sternberet et al.
JOURNAL OF IMMUNOLOGY (2016)
The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference
Thomas Trolle et al.
JOURNAL OF IMMUNOLOGY (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity
Geert P. M. Mommen et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Neoantigen landscape dynamics during human melanoma-T cell interactions
Els M. E. Verdegaal et al.
NATURE (2016)
A large fraction of HLA class I ligands are proteasome-generated spliced peptides
Juliane Liepe et al.
SCIENCE (2016)
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
Erlend Stronen et al.
SCIENCE (2016)
Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames
Celine M. Laumont et al.
NATURE COMMUNICATIONS (2016)
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Michal Bassani-Sternberg et al.
NATURE COMMUNICATIONS (2016)
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
Shelly Kalaora et al.
ONCOTARGET (2016)
Neoantigen-based cancer immunotherapy
Sara Bobisse et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Enhanced Recognition of HIV-1 Cryptic Epitopes Restricted by HLA Class I Alleles Associated With a Favorable Clinical Outcome
Anju Bansal et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Tumor neoantigens: building a framework for personalized cancer immunotherapy
Matthew M. Gubin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules
Celia R. Berkers et al.
JOURNAL OF IMMUNOLOGY (2015)
Peptide Splicing in the Proteasome Creates a Novel Type of Antigen with an Isopeptide Linkage
Celia R. Berkers et al.
JOURNAL OF IMMUNOLOGY (2015)
Extended O-GIcNAc on HLA Class-I-Bound Peptides
Fabio Marino et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Novor: Real-Time Peptide de Novo Sequencing Software
Bin Ma
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2015)
Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation
Michal Bassani-Sternberg et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry
Jennifer G. Abelin et al.
NATURE PROTOCOLS (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression
Jelle Scholtalbers et al.
GENOME MEDICINE (2015)
An open-source computational and data resource to analyze digital maps of immunopeptidomes
Etienne Caron et al.
ELIFE (2015)
The immune epitope database (IEDB) 3.0
Randi Vita et al.
NUCLEIC ACIDS RESEARCH (2015)
The IPD and IMGT/HLA database: allele variant databases
James Robinson et al.
NUCLEIC ACIDS RESEARCH (2015)
Increased Diversity of the HLA-B40 Ligandome by the Presentation of Peptides Phosphorylated at Their Main Anchor Residue
Miguel Marcilla et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Proteogenomics: concepts, applications and computational strategies
Alexey I. Nesvizhskii
NATURE METHODS (2014)
Cryptic MHC class I-binding peptides are revealed by aminoglycoside-induced stop codon read-through into the 3′ UTR
Elliot Goodenough et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD)
Geert P. M. Mommen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
HLA ligandome tumor antigen discovery for personalized vaccine approach
Hans-Georg Rammensee et al.
EXPERT REVIEW OF VACCINES (2013)
NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ
Edita Karosiene et al.
IMMUNOGENETICS (2013)
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
Nienke van Rooij et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Paul F. Robbins et al.
NATURE MEDICINE (2013)
MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia
Mark Cobbold et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Getting Personal with Neoantigen-Based Therapeutic Cancer Vaccines
Nir Hacohen et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy
Valerie Dutoit et al.
BRAIN (2012)
High Immunogenicity of the Human Leukocyte Antigen Peptidomes of Melanoma Tumor Cells
Saulius Jarmalavicius et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Major Histocompatibility Complex Class II+ Invariant Chain Negative Breast Cancer Cells Present Unique Peptides that Activate Tumor-specific T Cells from Breast Cancer Patients
Olesya Chornoguz et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Proteomic Study and Marker Protein Identification of Caenorhabditis elegans Lipid Droplets
Peng Zhang et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
The Human Immunopeptidome Project, a Suggestion for yet another Postgenome Next Big Thing
Arie Admon et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
A survey of computational methods and error rate estimation procedures for peptide and protein identification in shotgun proteomics
Alexey I. Nesvizhskii
JOURNAL OF PROTEOMICS (2010)
Soluble plasma HLA peptidome as a potential source for cancer biomarkers
Michal Bassani-Sternberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
NetMHCpan, a method for MHC class I binding prediction beyond humans
Ilka Hoof et al.
IMMUNOGENETICS (2009)
Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy
Florence R. Depontieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identification of breast cancer peptide epitopes presented by HLA-A*0201
Oriana E. Hawkins et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self
Fiyaz Mohammed et al.
NATURE IMMUNOLOGY (2008)
NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11
Claus Lundegaard et al.
NUCLEIC ACIDS RESEARCH (2008)
Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction
Mette V. Larsen et al.
BMC BIOINFORMATICS (2007)
Identification and characterization of T-cell epitopes deduced from RGS5, a novel broadly expressed tumor antigen
Cristina N. Boss et al.
CLINICAL CANCER RESEARCH (2007)
Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy
Angela L. Zarling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The Tubingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy
H Singh-Jasuja et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo
AL Zarling et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Identification of T cell ligands in a library of peptides covalently attached to HLA-DR4
E Boen et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
